Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Methyl 3 Trifluoromethyl Aniline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis patent CN121202708A offers high-purity intermediates. Efficient scale-up reduces costs and ensures supply chain reliability for global buyers.
Novel patent CN119707699A offers green synthesis for MTA. Reduces cost and improves supply chain reliability for veterinary drug manufacturers globally.
Patent CN114920655A reveals a cost-effective nitration-fluorination-reduction route for high-purity 2-fluoro-3-trifluoromethylaniline, offering significant supply chain advantages.
Patent CN114890902B details a safer, two-step synthesis for 2-methyl-3-trifluoromethyl aniline, offering significant cost reduction in API manufacturing.